First Quadrant L P CA Reduces Position in UnitedHealth Group Incorporated (UNH)
First Quadrant L P CA decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 107,577 shares of the healthcare conglomerate’s stock after selling 2,946 shares during the quarter. First Quadrant L P CA’s holdings in UnitedHealth Group were worth $21,069,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Marshall Wace LLP boosted its holdings in shares of UnitedHealth Group by 441.4% in the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after buying an additional 11,361 shares during the last quarter. American Century Companies Inc. lifted its holdings in UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after purchasing an additional 681,111 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in UnitedHealth Group by 5.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares in the last quarter. Essex Financial Services Inc. lifted its holdings in UnitedHealth Group by 12.3% during the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after purchasing an additional 967 shares in the last quarter. Finally, Factory Mutual Insurance Co. lifted its holdings in UnitedHealth Group by 20.9% during the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after purchasing an additional 72,000 shares in the last quarter. 85.97% of the stock is currently owned by institutional investors.
In other news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now owns 61,137 shares in the company, valued at $13,652,503.47. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares in the company, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,630 shares of company stock worth $7,669,416. Company insiders own 0.89% of the company’s stock.
Several equities analysts have weighed in on UNH shares. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Credit Suisse Group started coverage on shares of UnitedHealth Group in a report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price target on the stock. Wells Fargo & Co reaffirmed an “outperform” rating and set a $245.00 price target (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, Royal Bank of Canada lifted their price target on shares of UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a report on Wednesday, November 29th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $224.56.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at $220.00 on Friday. The stock has a market cap of $211,090.00, a P/E ratio of 25.00, a PEG ratio of 1.65 and a beta of 0.66. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a 1 year low of $156.09 and a 1 year high of $231.77.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.17 earnings per share. sell-side analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.36%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s payout ratio is currently 34.09%.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.